Rodrigues Elizabeth M, Scudder Samantha L, Goo Marisa S, Patrick Gentry N
University of California San Diego, Section of Neurobiology, Division of Biological Sciences, La Jolla, California 92093-0347.
University of California San Diego, Section of Neurobiology, Division of Biological Sciences, La Jolla, California 92093-0347
J Neurosci. 2016 Feb 3;36(5):1590-5. doi: 10.1523/JNEUROSCI.2964-15.2016.
Alzheimer's disease (AD) is a neurodegenerative disease in which patients experience progressive cognitive decline. A wealth of evidence suggests that this cognitive impairment results from synaptic dysfunction in affected brain regions caused by cleavage of amyloid precursor protein into the pathogenic peptide amyloid-β (Aβ). Specifically, it has been shown that Aβ decreases surface AMPARs, dendritic spine density, and synaptic strength, and also alters synaptic plasticity. The precise molecular mechanisms by which this occurs remain unclear. Here we demonstrate a role for ubiquitination in Aβ-induced synaptic dysfunction in cultured rat neurons. We find that Aβ promotes the ubiquitination of AMPARs, as well as the redistribution and recruitment of Nedd4-1, a HECT E3 ubiquitin ligase we previously demonstrated to target AMPARs for ubiquitination and degradation. Strikingly, we show that Nedd4-1 is required for Aβ-induced reductions in surface AMPARs, synaptic strength, and dendritic spine density. Our findings, therefore, indicate an important role for Nedd4-1 and ubiquitin in the synaptic alterations induced by Aβ.
Synaptic changes in Alzheimer's disease (AD) include surface AMPAR loss, which can weaken synapses. In a cell culture model of AD, we found that AMPAR loss correlates with increased AMPAR ubiquitination. In addition, the ubiquitin ligase Nedd4-1, known to ubiquitinate AMPARs, is recruited to synapses in response to Aβ. Strikingly, reducing Nedd4-1 levels in this model prevented surface AMPAR loss and synaptic weakening. These findings suggest that, in AD, Nedd4-1 may ubiquitinate AMPARs to promote their internalization and weaken synaptic strength, similar to what occurs in Nedd4-1's established role in homeostatic synaptic scaling. This is the first demonstration of Aβ-mediated control of a ubiquitin ligase to regulate surface AMPAR expression.
阿尔茨海默病(AD)是一种神经退行性疾病,患者会经历渐进性认知衰退。大量证据表明,这种认知障碍是由淀粉样前体蛋白裂解为致病性肽淀粉样β(Aβ)导致受影响脑区突触功能障碍引起的。具体而言,已表明Aβ会降低表面AMPA受体、树突棘密度和突触强度,还会改变突触可塑性。其发生的确切分子机制仍不清楚。在这里,我们证明了泛素化在培养的大鼠神经元中Aβ诱导的突触功能障碍中的作用。我们发现Aβ促进AMPA受体的泛素化,以及Nedd4-1的重新分布和募集,Nedd4-1是一种HECT E3泛素连接酶,我们之前证明它靶向AMPA受体进行泛素化和降解。令人惊讶的是,我们表明Nedd4-1是Aβ诱导的表面AMPA受体减少、突触强度和树突棘密度降低所必需的。因此,我们的研究结果表明Nedd4-1和泛素在Aβ诱导的突触改变中起重要作用。
阿尔茨海默病(AD)中的突触变化包括表面AMPA受体丧失,这会削弱突触。在AD的细胞培养模型中,我们发现AMPA受体丧失与AMPA受体泛素化增加相关。此外,已知会使AMPA受体泛素化的泛素连接酶Nedd4-1会响应Aβ被募集到突触。令人惊讶的是,在该模型中降低Nedd4-1水平可防止表面AMPA受体丧失和突触减弱。这些发现表明,在AD中,Nedd4-1可能使AMPA受体泛素化以促进其内化并削弱突触强度,类似于Nedd4-1在稳态突触缩放中的既定作用。这是Aβ介导的对泛素连接酶的控制以调节表面AMPA受体表达的首次证明。